11HQ image
Deposition Date 2026-02-25
Release Date 2026-05-27
Last Version Date 2026-07-01
Entry Detail
PDB ID:
11HQ
Keywords:
Title:
Type-III c-MET Inhibitor Enabled by Free-Energy Perturbation Calculations
Biological Source:
Source Organism(s):
Homo sapiens (Taxon ID: 9606)
Expression System(s):
Method Details:
Experimental Method:
Resolution:
2.65 Å
R-Value Free:
0.28
R-Value Work:
0.22
Space Group:
P 21 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Hepatocyte growth factor rece
Gene (Uniprot):MET
Mutagens:L1272V
Chain IDs:A, B, C
Chain Length:310
Number of Molecules:3
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Discovery of 2H-Pyrrolo[3,4‐ c ]pyridin-3-one Derivatives as Type-III c‐MET Inhibitors Enabled by Free-Energy Perturbation Calculations.
Acs Med.Chem.Lett. 17 1364 1372 (2026)
PMID: 42305208 DOI: 10.1021/acsmedchemlett.6c00158

Abstact

The clinical emergence of diverse c-MET mutations with resistance to approved inhibitors has created an urgent demand for next-generation inhibitors with efficacy against c-MET-resistant mutations while maintaining c-MET wild-type (WT) potency, selectivity over other kinases, and brain penetration. Here, we report a novel chemical series discovered through iterative core enumeration and decoration guided by free energy perturbation calculations. Type-III inhibitor 20 demonstrated potent activity against both WT and c-MET with the D1228V resistance mutation with promising physicochemical properties, laying the foundation for the development of brain-penetrant therapies targeting c-MET-driven cancers.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback